HomeNew
Premium
Latest
E-paper
Companies
Economy
Blueprint
Finance
Budget
Industry
Markets
External Affairs Defence Security
World News
Opinion
India News
Technology
Specials
Partner Content
Multimedia
sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
NewslettersNew
WebstoriesNew
Politics
Management
Sudoku
Crossword
BS Apps
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Trade resents losses due to government's faults
It is now for the industry associations to agitate the matter before the government
Is Mankindss Pharma IPO worth a subscription? Here's what brokerages
In the grey markets, shares of Mankind Pharma enjoyed a premium of Rs 90, which translated to a likely listing price of Rs 1,170 per share on the upper price band
Little scope for RBI to take its foot off the gas
The RBI need not match the Fed one-to-one but there seems little scope to take its foot off the gas
